Literature DB >> 21913965

Magnetic resonance imaging retinal oximetry: a quantitative physiological biomarker for early diabetic retinopathy?

Y Yang1, X R Zhu, Q G Xu, H Metcalfe, Z C Wang, J K Yang.   

Abstract

AIMS: To assess the efficacy of using magnetic resonance imaging measurements of retinal oxygenation response to detect early diabetic retinopathy in patients with Type 2 diabetes.
METHODS: Magnetic resonance imaging was conducted during 100% oxygen inhalation in patients with Type 2 diabetes with either no diabetic retinopathy (n = 12) or mild to moderate background diabetic retinopathy (n = 12), as well as in healthy control subjects (n = 12). Meanwhile, changes in retinal oxygenation response were measured.
RESULTS: In the healthy control group, levels of retinal oxygenation response increased slowly during 100% oxygen inhalation. In contrast, they increased more quickly and attained homeostasis much earlier in the groups with background diabetic retinopathy (at the 20-min time point) and with no diabetic retinopathy (at the 25-min time point) than in the healthy control group (at the 42-min time point). Furthermore, levels of retinal oxygenation response in the group with background diabetic retinopathy increased more than that of the group with no diabetic retinopathy, which in turn increased more than that of the healthy control group. There are statistically significant differences between the group with background diabetic retinopathy and the healthy control group at 6-, 8-, 10-, 15-, 20- and 25-min time points (P < 0.05). According to the normal range of the healthy control group by setting fundus photography results as 'gold standard' in our research, the sensitivity, specificity, positive predictive value, negative predictive value and receiver operating characteristic area for reporting the early indications of utility of diabetic retinopathy were 83.33%, 58.33%, 50%, 87.5% and 0.774, respectively.
CONCLUSIONS: The results indicate that magnetic resonance imaging is a potential screening method and probably a quantitative physiological biomarker to find early diabetic retinopathy in patients with Type 2 diabetes.
© 2011 The Authors. Diabetic Medicine © 2011 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21913965     DOI: 10.1111/j.1464-5491.2011.03440.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  7 in total

1.  Luminescent Probe Based Techniques for Hypoxia Imaging.

Authors:  Sana Sandhu; LeNaiya Kydd; Justyn Jaworski
Journal:  J Nanomed Res       Date:  2017-11-20

2.  Applications of azo-based probes for imaging retinal hypoxia.

Authors:  Md Imam Uddin; Stephanie M Evans; Jason R Craft; Lawrence J Marnett; Md Jashim Uddin; Ashwath Jayagopal
Journal:  ACS Med Chem Lett       Date:  2015-02-12       Impact factor: 4.345

3.  Diabetic Retinopathy-Update on Prevention Techniques, Present Therapies, and New Leads.

Authors:  Lauren M Marozas; Patrice E Fort
Journal:  US Ophthalmic Rev       Date:  2014

4.  [Prognostic value of cardiovascular MRI in diabetics].

Authors:  C L Schlett; R C Bertheau; H-U Kauczor; S Weckbach
Journal:  Radiologe       Date:  2015-04       Impact factor: 0.635

5.  An analysis of the correlation between diabetic retinopathy and preretinal oxygen tension using three-dimensional spoiled gradient-recalled echo sequence imaging.

Authors:  Min-Jie Zhou; Ju-Wei Shao; Jian Pu; Shu-Tian Xiang; Yi Liang; Qian He; Wei Su; Cheng Liu
Journal:  BMC Med Imaging       Date:  2022-07-05       Impact factor: 2.795

6.  Whole-Body MR Imaging Including Angiography: Predicting Recurrent Events in Diabetics.

Authors:  Robert C Bertheau; Fabian Bamberg; Elena Lochner; Hannes M Findeisen; Klaus G Parhofer; Hans-Ulrich Kauczor; Stefan O Schoenberg; Sabine Weckbach; Christopher L Schlett
Journal:  Eur Radiol       Date:  2015-08-25       Impact factor: 5.315

7.  In Vivo Imaging of Retinal Hypoxia in a Model of Oxygen-Induced Retinopathy.

Authors:  Md Imam Uddin; Stephanie M Evans; Jason R Craft; Megan E Capozzi; Gary W McCollum; Rong Yang; Lawrence J Marnett; Md Jashim Uddin; Ashwath Jayagopal; John S Penn
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.